HSV-1 vs HSV-2 in Newborns: What Is the Difference?

A neonatal herpes simplex virus (HSV) diagnosis is terrifying for any parent, and it is completely normal to feel overwhelmed. Learning whether your baby has HSV-1 or HSV-2 is an important step in understanding their care. Both types of the virus can cause the same forms of serious neonatal disease, and both receive the same urgent initial intravenous (IV) antiviral treatment ^[1][2].

Ultimately, the overall path to recovery depends much more on where the infection has spread in the baby’s body and how quickly treatment begins, rather than on the virus type alone ^[1][2]. However, knowing the specific type (HSV-1 or HSV-2) provides the care team with useful information about how often the virus might reactivate on the skin later in childhood and how to structure long-term treatment ^[3][2].

Which Type is More Common in Newborns?

Globally, HSV-2 is the most common cause of neonatal herpes, accounting for roughly 71% of estimated cases worldwide ^[4]. This is largely because HSV-2 is the traditional cause of genital herpes, and babies are most often exposed to the virus in the birth canal during delivery ^[5].

However, in many high-income regions like North America and Europe, HSV-1 is becoming increasingly common and is even the dominant cause of neonatal herpes in some countries ^[6]. This shift is happening because HSV-1 (which traditionally causes oral cold sores) is now a leading cause of new genital herpes infections in young adults ^[7]. Furthermore, babies can also catch HSV-1 after birth if they are exposed to the oral secretions of someone with an active cold sore (for example, through kissing) ^[6].

Because HSV is often spread through “asymptomatic shedding”—meaning the virus is active on the skin or in secretions but causes no visible sores—many families never know exactly when or from whom their baby acquired the virus. This is incredibly common and not your fault ^[5].

How Do the Two Types Differ in Recovery?

While both viruses are treated immediately with antiviral medications, there are clinical differences in how the two types behave over time.

• Skin Recurrences: Babies who recover from an HSV-2 infection are more likely to experience recurrent skin outbreaks (blisters) as they grow older compared to those with HSV-1 ^[2]. In a large observational study following infants treated between 1980 and 2016, 80% of babies with HSV-2 had subsequent skin recurrences, compared to 55% of babies with HSV-1 ^[2]. These percentages are historical averages, not a direct prediction for your child.
• Central Nervous System (CNS) Disease: If the virus reaches the brain and spinal cord, it causes CNS disease. This condition carries a high risk for neurological issues regardless of the virus type. In the same historical cohort, only about 55% of infants with CNS disease recovered without obvious neurological abnormalities at 24 months of age ^[2]. While HSV-2 has sometimes been associated in medical literature with concerns for worse neurological outcomes, recent data shows that the extent of the infection and how early treatment starts are the most critical factors for a baby’s prognosis, not just the virus type ^[1][2].
• Long-Term Treatment Benefits: Research into follow-up care has identified some differences between the types. In a major clinical review, giving babies with HSV-2 CNS infections six months of suppressive oral antiviral medication (acyclovir) after their initial IV treatment significantly improved their long-term neurological outcomes ^[3]. While that specific study did not show the same statistical benefit for babies with HSV-1 brain infections, this does not mean the treatment doesn’t work for HSV-1. In clinical practice, care teams frequently recommend a 6-month course of oral suppression for both types of CNS or disseminated infections to help prevent recurrences and support the safest recovery ^[3].

What Matters Most for Your Baby’s Prognosis

The specific virus type is just one piece of the puzzle. The most vital factors for your baby’s recovery include:

• Disease Extent: Infections confined strictly to the skin, eyes, and mouth (SEM disease) have the most favorable prognosis, though they still require urgent care. Disseminated disease (where the virus spreads throughout the body’s internal organs like the liver or lungs) has the highest risk of mortality, while CNS disease carries the highest risk of long-term neurological challenges ^[1][2].
• Prompt IV Treatment: Starting IV antiviral therapy as early as possible is associated with significantly better outcomes ^[2]. Treatment typically involves a multi-week course of IV medication, with the exact duration (often 14 to 21 days or more) determined by whether the infection is limited to the skin or has spread to the CNS or organs.

🚨 Urgent Warning Signs

Neonatal HSV can progress quickly, and recurrences can happen even after treatment. Seek emergency medical care immediately (do not wait for a scheduled appointment) if your baby develops:

• A fever (rectal temperature of 100.4°F / 38°C or higher) or an unusually low body temperature
• New skin blisters or eye redness/discharge
• Poor feeding or unusual sleepiness/lethargy
• Seizures or abnormal repetitive movements
• Difficulty breathing